Clara Duran-Castells

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control

M. Esteller, B. Clotet, J. Martinez-Picado, 2020, PLoS pathogens.

Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections

À. Olvera, Joaquín Sánchez, B. Mothe, 2022, Frontiers in Immunology.

Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells

J. Díez, A. Meyerhans, M. David, 2022, bioRxiv.

TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses

B. Clotet, À. Olvera, J. Martinez-Picado, 2020, The Journal of Immunology.

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

M. Esteller, R. Paredes, B. Clotet, 2022, EBioMedicine.

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

B. Clotet, T. Wyss-Coray, J. Martinez-Picado, 2023, Journal of virology.

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination

B. Clotet, J. Martinez-Picado, T. Hanke, 2023, EBioMedicine.